Canntab Therapeutics Limited
PILL
Kedudukan dalam Saham
#40496
Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office... Canntab Therapeutics Limited, a phytopharmaceutical firm with its main office in Markham, Canada, is dedicated to the research and development of sophisticated, medical-grade cannabinoid compounds. The company's diverse portfolio within Canada includes various orally administered pharmaceutical cannabis products. These innovative dosage forms encompass extended-release cannabinoid pellets, rapid-onset cannabidiol options, multi-layered modified-release formulations, quickly dissolving flash-melt versions, and dual-layer cannabinoid tablets. Canntab's products are designed to address a wide spectrum of health concerns, such as sleep disturbances, post-traumatic stress disorder, social anxiety, different forms of addiction, arthritic conditions, general pain management, alleviating pain and stimulating appetite for cancer patients, and aiding in recovery from opioid and other painkiller dependencies.
Harga Saham
$0.0036163
Disegerakkan terakhir: 2023-10-30
Modal Pasaran
$118.21K
Perubahan (1 hari)
0.39%
Perubahan (1 tahun)
3,516.30%
Negara
CA
Perdagangan Canntab Therapeutics Limited (PILL)
Kategori
Healthcare
Sejarah pecahan saham untuk Canntab Therapeutics Limited (PILL)
Saham Canntab Therapeutics Limited (simbol: PILL) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham PILL yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham PILL.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham PILL yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham PILL.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
